Karen Steber
Family · Iron Mountain, MINPI 1992725493
Payments from drug & device makers
Across 73 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$507
- Merck$129
- Pfizer$124
- Bayer$87
- Lilly USA, LLC$68
- Novo Nordisk$66
- plus $439 from 17 others
What the payments were for
- Food & beverage$1,420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $507 |
| Merck | 7 | $129 |
| Pfizer | 8 | $124 |
| Bayer | 5 | $87 |
| Lilly USA, LLC | 4 | $68 |
| Novo Nordisk | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Novartis | 2 | $42 |
| Medtronic | 1 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $31 |
| Johnson & Johnson | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Edwards Lifesciences | 1 | $18 |
| Corium, LLC | 2 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| GSK | 1 | $13 |
How this compares
$1,420 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $44,365 |
| JardianceEmpagliflozin | 27 | $35,266 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $21,098 |
| OzempicSemaglutide | 12 | $11,395 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $7,377 |
| Wixela InhubFluticasone Propion/Salmeterol | 19 | $4,562 |
| SynthroidLevothyroxine Sodium | 35 | $2,003 |
| Atorvastatin Calcium | 272 | $1,698 |
| Fluoxetine Hcl | 69 | $1,692 |
| Metoprolol Succinate | 112 | $1,681 |
| Omeprazole | 142 | $1,148 |
| Levothyroxine Sodium | 146 | $1,130 |
| Lisinopril | 159 | $884 |
| Tamsulosin Hcl | 46 | $776 |
| Rosuvastatin Calcium | 78 | $757 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $44,36551 claims |
| Boehringer IngelheimJardiance | $31 | $35,26627 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $13 | $28,47541 claims |
| Novo NordiskOzempic | $66 | $11,39512 claims |
| AbbVieSynthroid | $507 | $2,00335 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,657 family providers in Michigan.
Other family in Iron Mountain
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.